The Effect of Oral Vitamin D Supplements on Fusion Outcome in Patients Receiving Elective Lumbar Spinal Fusion
NCT ID: NCT05023122
Last Updated: 2021-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2016-01-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications
NCT04229368
Does Supplementing Vitamin D Deficiency Affect Fusion Healing Rates in Elective Foot and Ankle Surgery?
NCT04450199
Relationships Between Vitamin D and Orthopedic Trauma
NCT04564625
Hip Arthroplasty and Vitamin D Status
NCT02295228
The Effect of Hypovitaminosis D and Vitamin D Supplementation on Fracture Nonunion Rates
NCT01691833
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vitamin D3 + calcium
vitamin D3 (cholecalciferol) 800 IU QD and calcium citrate 600 mg QD, given from postoperative day 1 and lasted for 3 months
vitamin D3
vitamin D3 (cholecalciferol) 800 IU QD
calcium
calcium citrate 600 mg QD
calcium only
only calcium citrate 600 mg QD, given from postoperative day 1 and lasted for 3 months
calcium
calcium citrate 600 mg QD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vitamin D3
vitamin D3 (cholecalciferol) 800 IU QD
calcium
calcium citrate 600 mg QD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indicated of elective spine fusion surgery for spinal stenosis or degenerative spondylolisthesis at the study hospital from January 2016 to December 2017.
Exclusion Criteria
* History of previous spine surgery
* Hemodialysis
* Long-term steroid use
* History of medical treatments for osteoporosis
* Postoperative follow-up for less than 12 months
* Newly-onset compression fracture after study procedure
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Show Chwan Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pei-Yuan Lee, MD
Honorary President
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pei-Yuan Lee, MD, PhD
Role: STUDY_DIRECTOR
Show Chwan Memorial Hospital, Changhua, Taiwan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Show Chwan Memorial Hospital
Changhua, Changhua, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hu MH, Tseng YK, Chung YH, Wu NY, Li CH, Lee PY. The efficacy of oral vitamin D supplements on fusion outcome in patients receiving elective lumbar spinal fusion-a randomized control trial. BMC Musculoskelet Disord. 2022 Nov 18;23(1):996. doi: 10.1186/s12891-022-05948-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD105014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.